Camlin Fine Sciences Limited
CAMLINFINE.BO · Bombay Stock Exchange · INR
78,61INR
+1,04 (+1,34 %)Stand 9. Nov., 9:59
Kennzahlen
- Eröffnung
- 77,78
- Vortag
- 77,57
- Tagesspanne
- 76,51 – 79,12
- 52 Wochen
- 73,50 – 192,00
- Volumen
- 60.645
- Ø Volumen
- 61.936
- Börsenwert
- 15,09 Mrd. INR
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 0,7
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
Camlin Fine Sciences Limited, along with its subsidiaries, is actively engaged globally in the research, development, manufacturing, and distribution of specialized chemical products, functional ingredients, and additive blends. The company provides a comprehensive portfolio of shelf-life extension solutions, marketed under its Xtendra and NaSure brands. These solutions feature a variety of antioxidants, including synthetic compounds like Tertiary Butyl Hydroquinone, Butylated Hydroxy Anisole, and Ascorbyl palmitate, as well as plant-derived options such as mixed tocopherols, green tea extract, rosemary extract, and acerola extract. Furthermore, their offerings encompass mold inhibitors, preservatives, acidifiers, antibacterial agents, toxin binders, pellet binders, and growth promoters. Beyond shelf-life solutions, Camlin Fine Sciences also supplies aroma ingredients like vanillin and ethyl vanillin, pharmaceutical and nutraceutical substances sourced through fermentation and plant extraction, and performance chemicals including hydroquinone and catechol. Its diverse product range serves a wide array of industries, including food and beverage, pet food and animal nutrition, rendering, aquaculture, petrochemical, pharmaceutical, agrochemical, dyes and pigment, biofuel, aroma technical, fragrance, and flavor sectors. Founded in 1931 and based in Mumbai, India, the company operated as Camlin Fine Chemicals Limited until its rebranding to Camlin Fine Sciences Limited in August 2011.
- CEO
- Ashish Subhash Dandekar
- Mitarbeitende
- 624
- Hauptsitz
- Mumbai, MA, IN
- Sektor
- Basic Materials
- Branche
- Chemicals - Specialty
- Börsengang
- 30. März 2007
- Website
- camlinfs.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.